Annual Shareholders Equity
$61.74 M
-$6.21 M-9.14%
31 March 2024
Summary:
Acasti Pharma annual stockholders equity is currently $61.74 million, with the most recent change of -$6.21 million (-9.14%) on 31 March 2024. During the last 3 years, it has risen by +$6.08 million (+10.93%). ACST annual shareholders equity is now -42.97% below its all-time high of $108.27 million, reached on 31 March 2022.ACST Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$56.13 M
-$3.23 M-5.44%
30 September 2024
Summary:
Acasti Pharma quarterly stockholders equity is currently $56.13 million, with the most recent change of -$3.23 million (-5.44%) on 30 September 2024. Over the past year, it has dropped by -$10.61 million (-15.90%). ACST quarterly shareholders equity is now -50.85% below its all-time high of $114.20 million, reached on 30 September 2021.ACST Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACST Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.1% | -15.9% |
| 3 y3 years | +10.9% | -50.9% |
| 5 y5 years | +459.0% | +4549.8% |
ACST Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -43.0% | +10.9% | -50.9% | at low |
| 5 y | 5 years | -43.0% | +459.0% | -50.9% | +1286.5% |
| alltime | all time | -43.0% | +1436.8% | -50.9% | +589.2% |
Acasti Pharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $56.13 M(-5.4%) |
| June 2024 | - | $59.36 M(-3.9%) |
| Mar 2024 | $61.74 M(-9.1%) | $61.74 M(-4.5%) |
| Dec 2023 | - | $64.68 M(-3.1%) |
| Sept 2023 | - | $66.75 M(+4.3%) |
| June 2023 | - | $64.01 M(-5.8%) |
| Mar 2023 | $67.95 M(-37.2%) | $67.95 M(-29.7%) |
| Dec 2022 | - | $96.72 M(-3.4%) |
| Sept 2022 | - | $100.16 M(-4.1%) |
| June 2022 | - | $104.40 M(-3.6%) |
| Mar 2022 | $108.27 M(+94.5%) | $108.27 M(-2.5%) |
| Dec 2021 | - | $111.06 M(-2.8%) |
| Sept 2021 | - | $114.20 M(+113.6%) |
| June 2021 | - | $53.46 M(-4.0%) |
| Mar 2021 | $55.66 M(+328.4%) | $55.66 M(+116.4%) |
| Dec 2020 | - | $25.71 M(+189.8%) |
| Sept 2020 | - | $8.87 M(-19.6%) |
| June 2020 | - | $11.04 M(-15.1%) |
| Mar 2020 | $12.99 M(+17.6%) | $12.99 M(-374.7%) |
| Dec 2019 | - | -$4.73 M(+275.0%) |
| Sept 2019 | - | -$1.26 M(-146.4%) |
| June 2019 | - | $2.72 M(-75.4%) |
| Mar 2019 | $11.04 M(+73.4%) | $11.04 M(-50.9%) |
| Dec 2018 | - | $22.48 M(-296.0%) |
| Sept 2018 | - | -$11.47 M(-300.2%) |
| June 2018 | - | $5.73 M(-10.0%) |
| Mar 2018 | $6.37 M(-60.9%) | $6.37 M(-47.4%) |
| Dec 2017 | - | $12.11 M(+1.5%) |
| Sept 2017 | - | $11.94 M(-18.2%) |
| June 2017 | - | $14.59 M |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | $16.27 M(-19.0%) | - |
| Nov 2016 | - | $14.71 M(-12.5%) |
| Aug 2016 | - | $16.81 M(-9.1%) |
| May 2016 | - | $18.50 M(-7.9%) |
| Feb 2016 | $20.09 M(-24.4%) | $20.09 M(-7.5%) |
| Nov 2015 | - | $21.71 M(-7.8%) |
| Aug 2015 | - | $23.55 M(-9.5%) |
| May 2015 | - | $26.02 M(-2.0%) |
| Feb 2015 | $26.56 M(-11.2%) | $26.56 M(-14.0%) |
| Nov 2014 | - | $30.89 M(+4.7%) |
| Aug 2014 | - | $29.51 M(-9.5%) |
| May 2014 | - | $32.61 M(+9.0%) |
| Feb 2014 | $29.91 M(+214.9%) | $29.91 M(+54.7%) |
| Nov 2013 | - | $19.34 M(-7.3%) |
| Aug 2013 | - | $20.85 M(+158.3%) |
| May 2013 | - | $8.07 M(-15.0%) |
| Feb 2013 | $9.50 M(-34.7%) | $9.50 M(-14.5%) |
| Nov 2012 | - | $11.11 M(-9.8%) |
| Aug 2012 | - | $12.32 M(-5.5%) |
| May 2012 | - | $13.04 M(-10.4%) |
| Feb 2012 | $14.55 M(+149.5%) | $14.55 M(+11.2%) |
| Nov 2011 | - | $13.09 M(+70.9%) |
| Aug 2011 | - | $7.66 M(-15.8%) |
| May 2011 | - | $9.09 M(+55.9%) |
| Feb 2011 | $5.83 M(+45.2%) | $5.83 M(-751.8%) |
| Nov 2010 | - | -$894.90 K(-79.6%) |
| Aug 2010 | - | -$4.38 M(+10.5%) |
| May 2010 | - | -$3.96 M(-198.7%) |
| Feb 2010 | $4.02 M | $4.02 M(-221.5%) |
| Nov 2009 | - | -$3.31 M |
FAQ
- What is Acasti Pharma annual stockholders equity?
- What is the all time high annual shareholders equity for Acasti Pharma?
- What is Acasti Pharma annual shareholders equity year-on-year change?
- What is Acasti Pharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Acasti Pharma?
- What is Acasti Pharma quarterly shareholders equity year-on-year change?
What is Acasti Pharma annual stockholders equity?
The current annual shareholders equity of ACST is $61.74 M
What is the all time high annual shareholders equity for Acasti Pharma?
Acasti Pharma all-time high annual stockholders equity is $108.27 M
What is Acasti Pharma annual shareholders equity year-on-year change?
Over the past year, ACST annual stockholders equity has changed by -$6.21 M (-9.14%)
What is Acasti Pharma quarterly stockholders equity?
The current quarterly shareholders equity of ACST is $56.13 M
What is the all time high quarterly shareholders equity for Acasti Pharma?
Acasti Pharma all-time high quarterly stockholders equity is $114.20 M
What is Acasti Pharma quarterly shareholders equity year-on-year change?
Over the past year, ACST quarterly stockholders equity has changed by -$10.61 M (-15.90%)